WallStreetZenWallStreetZen

NASDAQ: CBUS
Cibus Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CBUS

Based on 1 analyst offering 12 month price targets for Cibus Inc

Min Forecast
$3.00+86.34%
Avg Forecast
$3.00+86.34%
Max Forecast
$3.00+86.34%

Should I buy or sell CBUS stock?

Based on 1 analyst offering ratings for Cibus Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their CBUS stock forecasts and price targets.

CBUS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-25

1 of 1

Forecast return on equity

Is CBUS forecast to generate an efficient return?

Company
147.47%
Industry
16.64%
Market
167.75%
CBUS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CBUS forecast to generate an efficient return on assets?

Company
6.96%
Industry
23.56%
CBUS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CBUS earnings per share forecast

What is CBUS's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$1.09
Avg 2 year Forecast
-$0.87
Avg 3 year Forecast
-$0.54

CBUS revenue forecast

What is CBUS's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$5.3M+21.9%
Avg 2 year Forecast
$12.7M+191.65%
Avg 3 year Forecast
$48.5M+1,015.64%
CBUS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CBUS revenue growth forecast

How is CBUS forecast to perform vs Biotechnology companies and vs the US market?

Company
115.92%
Industry
32.82%
Market
13.54%
CBUS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CBUS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CBUS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CBUS$1.61$3.00+86.34%Hold
VANI$1.36$3.75+176.75%Strong Buy
RANI$0.87$7.33+739.98%Strong Buy
CNXU$4.68$20.00+327.35%Buy
BDTX$2.10$12.50+495.24%Strong Buy
View Top Biotech Stocks

Cibus Stock Forecast FAQ

Is Cibus Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CBUS) stock is to Hold CBUS stock.

Out of 1 analyst, 0 (0%) are recommending CBUS as a Strong Buy, 0 (0%) are recommending CBUS as a Buy, 1 (100%) are recommending CBUS as a Hold, 0 (0%) are recommending CBUS as a Sell, and 0 (0%) are recommending CBUS as a Strong Sell.

If you're new to stock investing, here's how to buy Cibus stock.

What is CBUS's earnings growth forecast for 2026-2028?

(NASDAQ: CBUS) Cibus's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.13%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.15%.

Cibus's earnings in 2026 is -$98,194,000.On average, 5 Wall Street analysts forecast CBUS's earnings for 2026 to be -$83,414,571, with the lowest CBUS earnings forecast at -$84,637,435, and the highest CBUS earnings forecast at -$81,052,916. On average, 5 Wall Street analysts forecast CBUS's earnings for 2027 to be -$66,653,700, with the lowest CBUS earnings forecast at -$80,143,412, and the highest CBUS earnings forecast at -$51,360,264.

In 2028, CBUS is forecast to generate -$41,317,498 in earnings, with the lowest earnings forecast at -$41,944,215 and the highest earnings forecast at -$40,125,206.

What is CBUS's revenue growth forecast for 2026-2028?

(NASDAQ: CBUS) Cibus's forecast annual revenue growth rate of 115.92% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 32.82%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.54%.

Cibus's revenue in 2026 is $4,347,000.On average, 5 Wall Street analysts forecast CBUS's revenue for 2026 to be $404,997,080, with the lowest CBUS revenue forecast at $299,601,539, and the highest CBUS revenue forecast at $482,190,334. On average, 5 Wall Street analysts forecast CBUS's revenue for 2027 to be $968,966,406, with the lowest CBUS revenue forecast at $524,302,693, and the highest CBUS revenue forecast at $1,384,357,825.

In 2028, CBUS is forecast to generate $3,706,575,467 in revenue, with the lowest revenue forecast at $749,003,847 and the highest revenue forecast at $5,874,941,605.

What is CBUS's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: CBUS) forecast ROA is 6.96%, which is lower than the forecast US Biotechnology industry average of 23.56%.

What is CBUS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CBUS price target, the average CBUS price target is $3.00, with the highest CBUS stock price forecast at $3.00 and the lowest CBUS stock price forecast at $3.00.

The Wall Street analyst predicted that Cibus's share price could reach $3.00 by Mar 25, 2027. The average Cibus stock price prediction forecasts a potential upside of 86.34% from the current CBUS share price of $1.61.

What is CBUS's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: CBUS) Cibus's current Earnings Per Share (EPS) is -$1.63. On average, analysts forecast that CBUS's EPS will be -$1.09 for 2026, with the lowest EPS forecast at -$1.11, and the highest EPS forecast at -$1.06. On average, analysts forecast that CBUS's EPS will be -$0.87 for 2027, with the lowest EPS forecast at -$1.05, and the highest EPS forecast at -$0.67. In 2028, CBUS's EPS is forecast to hit -$0.54 (min: -$0.55, max: -$0.53).

What is CBUS's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: CBUS) forecast ROE is 147.47%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.